Description
Now available in its Third Edition, Asthma: Basic Mechanisms and Clinical Management has become the reference text in asthma. This highly successful text sheds new light on the basic physiological and molecular mechanisms of asthma, how current treatments work, and how best to apply the latest knowledge to control this important disease. The Third Edition has undergone radical revision and includes several new chapters. It retains the virtues of the previous volumes by bringing together all of the recent research findings by internationally recognized experts on the causative mechanisms of asthma, including in-depth clinical aspects and therapy. The book presents an integrated approach toward the treatment of this disease with new concepts, changes in asthma management, and the development of new therapeutic agents. Asthma provides extensive references for researchers and clinicians who need to keep abreast of recent developments in this rapidly expanding field.
- Comprehensive coverage of both basic science and clinical aspects of asthma
- Extensively referenced throughout
Chapter
Chapter 2. Genetics
pp.:
62 – 74
Chapter 3. Airway Pathology in Asthma
pp.:
74 – 92
Chapter 4. Physiology
pp.:
92 – 116
Chapter 5. Airway Smooth Muscle Cells: Structure and Function
pp.:
116 – 140
Chapter 6. Mast Cells and Basophils
pp.:
140 – 154
Chapter 7. Monocytes, Macrophages and Dendritic Cells
pp.:
154 – 168
Chapter 8. Eosinophils
pp.:
168 – 186
Chapter 9. Lymphocytes
pp.:
186 – 214
Chapter 10. Epithelial Cells
pp.:
214 – 232
Chapter 11. Pathophysiology of Airway Mucus Secretion in Asthma
pp.:
232 – 256
Chapter 12. Tracheobronchial Circulation
pp.:
256 – 266
Chapter 13. Adhesion Molecules
pp.:
266 – 280
Chapter 14. Microvascular-Epithelial Exudation of Plasma
pp.:
280 – 296
Chapter 15. Prostaglandins and Thromboxane
pp.:
296 – 308
Chapter 16. Cysteinyl Leukotrienes
pp.:
308 – 324
Chapter 17. Kinins
pp.:
324 – 336
Chapter 18. Chemokines
pp.:
336 – 360
Color Plate Section
pp.:
354 – 974
Chapter 19. Lymphokines
pp.:
360 – 374
Chapter 20. Other Mediators of Asthma
pp.:
374 – 400
Chapter 21. Nitric Oxide
pp.:
400 – 420
Chapter 22. Neural Control of Airway Function in Asthma
pp.:
420 – 440
Chapter 23. Humoral Control of Airway Tone
pp.:
440 – 454
Chapter 24. NANC Nerves and Neuropeptides
pp.:
454 – 490
Chapter 25. Transcription Factors
pp.:
490 – 506
Chapter 26. Airway Remodelling
pp.:
506 – 518
Chapter 27. Pathophysiology of Asthma
pp.:
518 – 538
Chapter 28. Allergens
pp.:
538 – 560
Chapter 29. Occupational Asthma
pp.:
560 – 578
Chapter 30. Infections
pp.:
578 – 600
Chapter 31. Asthma Provoked by Exercise, Hyperventilation and the Inhalation of Non-isotonic Aerosols
pp.:
600 – 620
Chapter 32. Atmospheric Pollutants
pp.:
620 – 628
Chapter 33. Drug-induced Asthma
pp.:
628 – 638
Chapter 34. Aspirin-induced Asthma
pp.:
638 – 648
Chapter 35. Allergen Avoidance
pp.:
648 – 682
Chapter 36. B-Adrenoceptor Agonists
pp.:
682 – 708
Chapter 37. Anticholinergic Bronchodilators
pp.:
708 – 720
Chapter 38. Theophylline
pp.:
720 – 738
Chapter 39. Cromones
pp.:
738 – 756
Chapter 40. Glucocorticosteroids
pp.:
756 – 798
Chapter 41. Mediator Antagonists
pp.:
798 – 814
Chapter 42. Immunomodulators
pp.:
814 – 826
Chapter 43. Future Therapies for Asthma
pp.:
826 – 852
Chapter 44. Management of Severe Asthma
pp.:
852 – 866
Chapter 45. Management of Asthma in Adults
pp.:
866 – 890
Chapter 46. Asthma in Children
pp.:
890 – 934
Chapter 47. Pharmacoeconomics of Asthma Treatments
pp.:
934 – 948
Chapter 48. Education and Self-management
pp.:
948 – 958